FBT:CA:TSX-First Trust NYSE Arca Biotechnology ETF (CAD)

ETF | Others |

Last Closing

CAD 28.74

Change

0.00 (0.00)%

Market Cap

CAD 1.83M

Volume

500.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing FBT:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.44% 45% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.44% 45% F 44% F
Trailing 12 Months  
Capital Gain 15.65% 45% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.65% 45% F 46% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.21% N/A N/A 29% F
Dividend Return -1.21% N/A N/A 20% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.21% N/A N/A 79% B-
Risk Adjusted Return -9.87% N/A N/A 22% F
Market Capitalization 1.83M 3% F 1% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.